Diary - News All news Nosopharm joins ENABLE project

Nosopharm joins ENABLE project

Nosopharm joins European Gram-negative Antibacterial Engine (ENABLE) project to combat antibiotic resistance

The company aims to advance NOSO-95179, a promising antibacterial compound, to clinical stage for the treatment of multidrug-resistant Gram-negative infections

Nosopharm, a biotechnology company specialized in the research and development of new antibacterial molecules, announced it has been selected to join ENABLE (European Gram-negative Antibacterial Engine), a project working to advance the development of potential antibiotics against multidrug resistant Gram-negative infections.

Read the press release